<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) can be associated with systemic or <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0042384" disease_type="Disease or Syndrome" abbrv="">Vasculitides</z:e> (leucocytoclastic, <z:e sem="disease" ids="C0031036" disease_type="Disease or Syndrome" abbrv="">periarteritis nodosa</z:e>, micropolyangeitis, Wegener's <z:hpo ids='HP_0002955'>granulomatosis</z:hpo>), <z:e sem="disease" ids="C0032453" disease_type="Disease or Syndrome" abbrv="">relapsing polychondritis</z:e>, and <z:e sem="disease" ids="C0085077" disease_type="Disease or Syndrome" abbrv="">Sweet's syndrome</z:e> are the most commonly reported </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0005505'>Refractory anemia</z:hpo> with excess of blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>), transformed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> evolving to an <z:hpo ids='HP_0002488'>acute leukemia</z:hpo>, and <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>) are preferentially associated with these <z:e sem="disease" ids="C0042384" disease_type="Disease or Syndrome" abbrv="">vasculitides</z:e> or <z:e sem="disease" ids="C0442893" disease_type="Disease or Syndrome" abbrv="">systemic diseases</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="50858">Corticosteroids</z:chebi> are generally effective </plain></SENT>
<SENT sid="4" pm="."><plain>Immunosuppressive drugs expose these patients to infectious complications and increase the risk of transformation into <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Occurrence of <z:e sem="disease" ids="C0032453" disease_type="Disease or Syndrome" abbrv="">relapsing polychondritis</z:e> in a patient older than 60years is associated with a <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> in 40% of the cases </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C0085077" disease_type="Disease or Syndrome" abbrv="">Sweet's syndrome</z:e> is associated in 10% of the cases with <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="C0162323" disease_type="Disease or Syndrome" abbrv="">Polyarthritis</z:e> or <z:e sem="disease" ids="C0409702" disease_type="Disease or Syndrome" abbrv="">oligoarthritis</z:e> with systemic manifestations that include <z:hpo ids='HP_0001945'>fever</z:hpo>, <z:hpo ids='HP_0000988'>skin rash</z:hpo>, and more rarely serositis or <z:hpo ids='HP_0001878'>haemolytic anemia</z:hpo> can occur contemporarily to a <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's disease with intestinal involvement has been reported in patients presenting with <z:mp ids='MP_0004027'>trisomy</z:mp> 8 associated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Pathogenic mechanisms underlying the association between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and autoimmune or systemic disorders remain to be elucidated </plain></SENT>
</text></document>